For this reason, even if a routine comprehensive haematological screening could be too expensive to be performed in all patients affected by hearing loss, audiologists should at least investigate patients presenting with SSNHL through coagulation tests and eventually assess them for genetic and acquired prothrombotic factors (such as the factor V Leiden and prothrombin mutations). This evidence concerns the gene F2 and hearing loss disorder.